GEORGE R BLUMENSCHEIN to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.045
-
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin Cancer Res. 2013 Dec 15; 19(24):6967-75.
Score: 0.037
-
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39.
Score: 0.008